‘Korea Medical Cannabis Organization’ and ‘The Association of Korean Medicine’ Signed MOU Agreement
○ ‘Korea Medical Cannabis Organization’(Representative Rev. Sung Seok Kang) and ‘The Association of Korean Medicine’(President KMD. Hyug Yong Choi) Signed MOU Agreement on June 24, 2020
○ Through the agreement, both of organizations agreed to cooperate closely to expand the use of medical cannabis for disease treatment and health promotion purposes.
○ KMCO are the first organization in Asia to pass the ‘medical cannabis law’. As a result of the KMCO’s amendment campaign, the Korean National Assembly passed the “Act on Drug Management” (Medical Cannabis Act) on November 23, 2018 with 205 votes in favor, 1 vote in opposition and 15 votes.
○However, due to regulations of the Ministry of Food and Drug Safety, only ‘Cannabis-derived medicines’ are being prescribed at higher-level general hospitals. Only Epidiolex and Sativex are prescribed for patients with intractable epilepsy and multiple sclerosis.
○KMCO will conduct a medical cannabis prescription campaign as a herbal medicine through a MOU agreement with AKOM.
○At the ceremony, Rev. Kang said, ‘The domestic cannabis Prescription system should be designated as ‘essential business’ like the dispensaries in other countries.’
Contact: Secretariat +82 070-7788-2090
fax +82 02-322-0967